• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN TRAILBLAZER SUPPORT CATHETER; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN TRAILBLAZER SUPPORT CATHETER; CATHETER, PERCUTANEOUS Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thromboembolism (2654)
Event Date 07/02/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
This literature article report is a retrospective study which reviewed the cases in which complications occurred during below-the-knee (btk) endovascular treatments that were performed at our hospital from 2005 to 2014.Ten cases have been described herein.All the patients had diabetes and non-healing wounds on their feet and/or rest pain in their foot or leg, and therefore, endovascular treatment was performed for the btk arteries of the affected lower extremity.The complications that occurred during the procedure were classified into six categories¿vascular spasm, flow limiting dissection, perforation, broken guidewire, distal thromboembolism, and unusual puncture site bleeding.Each complication has its own solutions and management.Endovascular procedures were performed under local anesthesia by interventional radiologists in an interventional radiology suite.The common femoral artery (cfa) was punctured using a non-medtronic micropuncture set under ultrasound guidance and sheath insertion was performed.Angiography using non-ionic contrast medium or carbon dioxide (for patients with poor renal function) and digital subtraction angiography were performed through the sheath to evaluate entire lower extremity arteries.In addition to those with only btk artery lesions, some patients had lesions in the ilio-femoropopliteal arteries.Although all affected arteries were treated in these patients, this report only investigated the treatment of btk arteries.The steno-occlusive lesions of the btk arteries were crossed using dedicated 0.018 or 0.014 inch non-medtronic guidewires.A trailblazer support catheter and a non-medtronic guiding sheath were used to provide better support.An antegrade approach was initially attempted by puncturing the cfa.In cases with restricted or no access through the cfa, we attempted retrograde access via the distal btk vessels.In some cases, a pedal or plantar artery approach was also attempted.The btk lesion was passed using these approaches and balloon angioplasty was then performed.During the procedure, complications were detected with a follow-up angiogram and appropriately managed.At the end of the procedure, we confirmed the establishment of bloodflow in at least one btk artery to ensure perfusion to the patient¿s foot.Case 9: it was reported that a focal embolism was detected in the distal anterior tibial artery (ata) during an angioplasty for total occlusion of the ata with a 2.5 mm x 12 cm balloon.The embolism was resolved after aspiration thrombectomy using a 5-fr non-medtronic guiding catheter.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRAILBLAZER SUPPORT CATHETER
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
IE  
091708734
MDR Report Key10459218
MDR Text Key204555187
Report Number2183870-2020-00270
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
K092299
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 08/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/27/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/17/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age79 YR
-
-